Rates Hit 16-Year High, and Zuck and Musk Square Off Amid Threads Launch 7/6/23
CNBC's "Fast Money"
00:00
The FDA Approves a Major Alzheimer's Treatment
FDA has given the Alzheimer's treatment, LeCambie, full approval. Medicare says it will cover a lot of the costs, making the treatment accessible to a much wider population. One of the makers of that drug is A.Z.I, which worked in collaboration with Biogen. We're talking to the CEO, one of the companies behind that drug next.
Play episode from 40:00
Transcript
